Safety and Efficacy of Anakinra Treatment for Patients With Post Acute Covid Syndrome

NCT05926505 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

182

Enrollment

OTHER

Sponsor class

Conditions

Post-Acute COVID-19 Syndrome
Post-Acute COVID-19
Long COVID

Interventions

DRUG: Placebo
DRUG: Anakinra 149 MG/ML Prefilled Syringe [Kineret]

Sponsor

Hellenic Institute for the Study of Sepsis